SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
14-Jun-24 5:25 PM View: | Novak Alfred J Director | Pasithea Therapeutics Corp. (KTTA) | 13-Jun-24 | Grant | 2,750 | $5.62 | $15,455.00 | 367% 0.75K to 3.5K | |
14-Jun-24 5:25 PM View: | Novak Alfred J Director | Pasithea Therapeutics Corp. (KTTA) | 12-Jun-24 | Grant | 750 | $5.61 | $4,207.50 | 100% 0 to 0.75K | |
06-Jun-23 10:00 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 02-Jun-23 | Private Purchase | 30,000 | $0.43 | $12,930.00 | 2% 1.3M to 1.33M | |
28-Nov-22 4:00 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 28-Nov-22 | Grant | 5,000 | $0.98 | $4,900.00 | < 1% 1.28M to 1.29M | |
28-Nov-22 4:00 PM View: | Marques Tiago Chief Executive Officer Director | Pasithea Therapeutics Corp. (KTTA) | 25-Nov-22 | Grant | 2,000 | $1.03 | $2,060.00 | < 1% 817.21K to 819.21K | |
28-Nov-22 4:00 PM View: | Marques Tiago Chief Executive Officer Director | Pasithea Therapeutics Corp. (KTTA) | 23-Nov-22 | Grant | 7,206 | $1.01 | $7,260.12 | < 1% 810.0K to 817.21K | |
22-Nov-22 4:10 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 22-Nov-22 | Grant | 5,000 | $0.99 | $4,950.00 | < 1% 1.28M to 1.28M | |
17-Nov-22 4:34 PM View: | Dumesnil Simon Director | Pasithea Therapeutics Corp. (KTTA) | 17-Nov-22 | Grant | 40,000 | $1.06 | $42,400.00 | 400% 10.0K to 50.0K | |
17-Nov-22 4:34 PM View: | Dumesnil Simon Director | Pasithea Therapeutics Corp. (KTTA) | 15-Nov-22 | Grant | 10,000 | $1.07 | $10,700.00 | 100% 0 to 10.0K | |
26-Oct-22 5:35 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 26-Oct-22 | Grant | 5,000 | $1.10 | $5,500.00 | < 1% 1.27M to 1.28M | |
21-Oct-22 5:05 PM View: | Marques Tiago Chief Executive Officer Director | Pasithea Therapeutics Corp. (KTTA) | 21-Oct-22 | Grant | 5,000 | $1.07 | $5,356.00 | < 1% 805.0K to 810.0K | |
19-Oct-22 5:29 PM View: | Delaney David | Pasithea Therapeutics Corp. (KTTA) | 17-Oct-22 | Private Purchase | 1,000 | $1.11 | $1,110.00 | < 1% 226.52K to 227.52K | |
17-Oct-22 6:11 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 17-Oct-22 | Grant | 10,000 | $1.13 | $11,310.00 | < 1% 1.26M to 1.27M | |
30-Sep-22 4:36 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 29-Sep-22 | Purchase | 6,710 | $1.16 | $7,756.76 | < 1% 1.78M to 1.79M | |
30-Sep-22 4:36 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 28-Sep-22 | Private Purchase | 57,647 | $1.19 | $68,542.30 | 3% 1.72M to 1.78M | |
06-Sep-22 5:03 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 06-Sep-22 | Purchase | 21,748 | $1.13 | $24,631.80 | 1% 1.7M to 1.72M | |
06-Sep-22 5:03 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 02-Sep-22 | Purchase | 11,507 | $1.14 | $13,105.30 | < 1% 1.69M to 1.7M | |
06-Sep-22 5:03 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 01-Sep-22 | Private Purchase | 55,646 | $1.13 | $62,629.60 | 3% 1.64M to 1.69M | |
31-Aug-22 4:32 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 30-Aug-22 | Purchase | 17,828 | $1.15 | $20,452.30 | 1% 1.62M to 1.64M | |
31-Aug-22 4:32 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 29-Aug-22 | Private Purchase | 5,000 | $1.17 | $5,840.50 | < 1% 1.61M to 1.62M | |
26-Aug-22 4:30 PM View: | Geller Avi | Pasithea Therapeutics Corp. (KTTA) | 19-Aug-22 | Private Purchase | 54,644 | $1.30 | $70,938.80 | 5% 1.03M to 1.09M | |
18-Aug-22 7:35 PM View: | Shahinian Eric | Pasithea Therapeutics Corp. (KTTA) | 17-Aug-22 | Private Purchase | 155,773 | $1.21 | $188,283.00 | 11% 1.46M to 1.61M | |
30-Jun-22 4:15 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 29-Jun-22 | Grant | 5,000 | $1.00 | $5,000.00 | < 1% 1.27M to 1.27M | |
30-Jun-22 4:15 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 28-Jun-22 | Grant | 5,000 | $1.02 | $5,100.00 | < 1% 1.26M to 1.27M | |
27-Jun-22 4:15 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 27-Jun-22 | Grant | 5,000 | $1.00 | $5,000.00 | < 1% 1.26M to 1.26M | |
23-Jun-22 4:31 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 23-Jun-22 | Grant | 5,000 | $1.00 | $5,000.00 | < 1% 1.25M to 1.26M | |
23-Jun-22 5:10 PM View: | Marques Tiago Chief Executive Officer Director | Pasithea Therapeutics Corp. (KTTA) | 23-Jun-22 | Grant | 5,000 | $0.99 | $4,964.10 | < 1% 800.0K to 805.0K | |
22-Jun-22 4:30 PM View: | Steinman Lawrence Director | Pasithea Therapeutics Corp. (KTTA) | 21-Jun-22 | Grant | 652,174 | -- | -- | 109% 600.0K to 1.25M | |
22-Dec-21 5:00 PM View: | Marques Tiago Chief Executive Officer Director | Pasithea Therapeutics Corp. (KTTA) | 20-Dec-21 | Grant | 200,000 | -- | -- | 33% 600.0K to 800.0K |